The Globe and Mail reports in its Friday, July 21, edition that Canaccord Genuity analyst Mike Mueller started coverage on Tourmaline Oil with a "buy" recommendation and a $750 share target. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $80.17. Mr. Mueller says in a note: "With the company's strong track record of distributing excess FCF to shareholders via special dividends (incremental to its base dividend) and self-funded organic growth of 6 per cent (compound annual growth rate) through 2028, Tourmaline Oil offers investors the best of both worlds. In our view, Tourmaline Oil is one of the top vehicles to gain exposure to an improving macro backdrop for North American natural gas development with the onset of incremental LNG export capacity (of which Tourmaline Oil already benefits from)." The Globe reported on Jan. 25 that Desjardins Securities analyst Chris MacCulloch had reaffirmed his "buy" recommendation for Tourmaline Oil. In the item, he said he was "growing increasingly bullish on oil prices." Tourmaline Oil shares could then be had for $64.71. The Globe reported on March 28 that BMO rated Tourmaline "outperform." It was then worth $55.28.